Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia

dc.contributor.authorKilic, E
dc.contributor.authorGursoy-Özdemir, Y
dc.contributor.authorBolay, H
dc.contributor.authorKelestimur, H
dc.contributor.authorDalkara, T
dc.date.accessioned2026-08-12T17:41:18Z
dc.date.issued1999
dc.departmentFırat Üniversitesi
dc.description.abstractLarge infarcts develop in pinealectomized rats subjected to middle cerebral artery occlusion, which was attributed to loss of antioxidant action of melatonin. However, melatonin also has vascular actions, and pinealectomy may induce hypertension. The authors investigated (1) whether hemodynamic factors contribute to infarct development in pinealectomized rats, (2) whether melatonin administration can reverse the unfavorable effect of pinealectomy on infarct formation, and (3) whether melatonin can reduce the infarct volume in nonpinealectomized rats subjected to focal transient ischemia (2 hours middle cerebral artery occlusion, 22 hours reperfusion). Rats were pinealectomized 3 months before ischemia to eliminate any possible action of pinealectomy-induced hypertension on stroke. Blood pressure and regional CBF values during ischemia and reperfusion were not significantly different between pinealectomized and sham-operated rats, suggesting that pinealectomy-induced increase in infarct was not related to hemodynamic factors. The infarct volume resumed to the level of sham-operated rats on melatonin administration. Injection of melatonin (4 mg/kg) before both ischemia and reperfusion reduced infarct volume by 40% and significantly improved neurologic deficit scores in pinealectomized as well as sham-operated rats subjected to middle cerebral artery occlusion. These data suggest that physiologic melatonin release as well as exogenously given melatonin has a neuroprotective action in focal cerebral ischemia.
dc.identifier.doi10.1097/00004647-199905000-00005
dc.identifier.endpage516
dc.identifier.issn0271-678X
dc.identifier.issn1559-7016
dc.identifier.issue5
dc.identifier.orcid0000-0002-3357-7733
dc.identifier.orcid0000-0003-3943-7819
dc.identifier.orcid0000-0001-6494-8923
dc.identifier.orcid0000-0002-0860-8964
dc.identifier.pmid10326718
dc.identifier.scopus2-s2.0-0033509001
dc.identifier.scopusqualityQ1
dc.identifier.startpage511
dc.identifier.urihttps://doi.org/10.1097/00004647-199905000-00005
dc.identifier.urihttps://hdl.handle.net/11508/59272
dc.identifier.volume19
dc.identifier.wosWOS:000084948600005
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSage Publications Inc
dc.relation.ispartofJournal of Cerebral Blood Flow and Metabolism
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectmelatonin
dc.subjectpinealectomy
dc.subjectcerebral ischemia
dc.subjectneuroprotection
dc.subjectcerebral blood flow
dc.subjectantioxidants
dc.titlePinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia
dc.typeArticle

Dosyalar